Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -57.42% is 26% above its 2-year average of -77.32%, near the high end of its 2-year range (-127.74%–-50.17%).
0.12% above its 12-month average of -57.49%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -55.49%.
NET PROFIT MARGIN
-57.42%
NET PROFIT MARGIN AVG TTM
-57.49%
NET PROFIT MARGIN AVG 3Y
N/A
NET PROFIT MARGIN AVG 5Y
N/A
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+0.12%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.35%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
-16305.71%
vs the sector median at left
Market Cap
$396.93M
Net Profit Margin
-58.33%
TTM Avg
-67.34%
3Y Avg
-66.78%
5Y Avg
-66.78%
Market Cap
$402.17M
Net Profit Margin
0.00%
TTM Avg
-4061.84%
3Y Avg
-2030.92%
5Y Avg
-1353.95%
Market Cap
$404.24M
Net Profit Margin
-13.96%
TTM Avg
-29.79%
3Y Avg
-27.76%
5Y Avg
-25.86%
Market Cap
$405.74M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
2.00%
Market Cap
$406.58M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$385.15M
Net Profit Margin
-112.58%
TTM Avg
-193.15%
3Y Avg
-231.74%
5Y Avg
-161.96%
Market Cap
$411.00M
Net Profit Margin
15.71%
TTM Avg
4.99%
3Y Avg
-8.39%
5Y Avg
-22.57%
Market Cap
$411.21M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Carlsmed, Inc. (CARL) | $397.99M | -57.42% | -57.49% | N/A | N/A |
| Shoulder Innovations, Inc. (SI)vs › | $396.93M | -58.33% | -67.34% | -66.78% | -66.78% |
| Neurogene Inc. (NGNE)vs › | $402.17M | 0.00% | -4061.84% | -2030.92% | -1353.95% |
| Myriad Genetics, Inc. (MYGN)vs › | $404.24M | -13.96% | -29.79% | -27.76% | -25.86% |
| Atea Pharmaceuticals, Inc. (AVIR)vs › | $405.74M | 0.00% | 0.00% | 0.00% | 2.00% |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $406.58M | 0.00% | 0.00% | 0.00% | 0.00% |
| REGENXBIO Inc. (RGNX)vs › | $385.15M | -112.58% | -193.15% | -231.74% | -161.96% |
| Strata Critical Medical, Inc. (SRTA)vs › | $411.00M | 15.71% | 4.99% | -8.39% | -22.57% |
| MapLight Therapeutics, Inc. (MPLT)vs › | $411.21M | 0.00% | 0.00% | 0.00% | 0.00% |
| Orthofix Medical Inc. (OFIX)vs › | $380.37M | -7.41% | -13.48% | -12.88% | -9.86% |
Operating Margin
-61.1%
Net Profit Margin
-57.4%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -55.49% |
| 2026-03-31 | -53.96% |
| 2025-12-31 | -56.80% |
| 2025-09-30 | -65.21% |
| 2025-06-30 | -56.00% |
| 2025-03-31 | -56.23% |
| 2024-12-31 | -50.17% |
| 2024-09-30 | -118.56% |
| 2024-06-30 | -103.22% |
| 2024-03-31 | -107.10% |
| 2023-12-31 | -127.74% |
